Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Corey Jones is active.

Publication


Featured researches published by Corey Jones.


Neuroreport | 1995

Functional role of the prefrontal cortex in retrieval of memories: a PET study.

Shitij Kapur; Fergus I. M. Craik; Corey Jones; Gregory M. Brown; Sylvain Houle; Endel Tulving

Retrieval of information from episodic memory involves the processes invoked by the attempt to remember (retrieval attempt) as well as processes associated with the successful retrieval of stored information (ecphory). Previous PET studies of memory have shown an activation of the prefrontal cortex in memory retrieval tasks, and we hypothesised that this activation represents retreival attempt, not ecphory. This hypothesis was directly directed using [15O]H2 PET imaging in 19 healthy subjects who performed three matched tasks which involved different levels of retrieval attempt and ecphory. The results showed that retrieval attempt was associated with activation of the prefrontal cortex, right greater than left, while ecphory involved the posterior cortical regions. These findings illuminate the functional role of the different neuroanatomical regions involved in episodic remembering.


Molecular Psychiatry | 2002

Significant dissociation of brain and plasma kinetics with antipsychotics.

Johannes Tauscher; Corey Jones; Gary Remington; Robert B. Zipursky; Shitij Kapur

Current dosing regimens of psychotropic drugs are based on plasma kinetic considerations, although it is unclear whether plasma levels faithfully reflect brain kinetics of drugs.1,2 To examine this, we compared the kinetics of plasma levels of two widely used antipsychotics, olanzapine and risperidone, vs the time course of their effects in the brain. We used positron emission tomography (PET) and [11C]-labeled ligands to quantify striatal and extra-striatal dopamine-2 (D2), and cortical serotonin-2A (5-HT2A) receptor occupancy in healthy subjects after a single dose, and in patients chronically treated for psychosis. We found a significant dissociation of brain and plasma kinetics. Mean plasma elimination half-lives of single doses of olanzapine and risperidone were 24.2 and 10.3 h, respectively, whereas it took on average 75.2 h with olanzapine, and 66.6 h with risperidone to decline to 50% of their peak striatal D2 receptor occupancy. We found similar discrepancies between the time course of plasma levels and extra-striatal D2 as well as 5-HT2A receptor occupancy. Our results question the current reliance on plasma kinetics as the main basis for dosing regimens of antipsychotics. Studies of brain kinetics may provide a sounder basis for determining dosing schedules of psychotropic medications.


Nuclear Medicine Communications | 1997

Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using [18F]-setoperone PET imaging.

Shitij Kapur; Corey Jones; Jean N. DaSilva; Alan A. Wilson; Sylvain Houle

Position emission tomography (PET) imaging of 5-HT2 receptors can be potentially very useful in investigating neuropsychiatric disorders and their pharmacological treatments. [18F]-setoperone, a PET radio-ligand, has been shown to be useful for the delineation of 5-HT2 receptors in the cortex. However, there is no available data regarding the scan-rescan reliability of this technique. The purpose of this study was to assess the reliability of the [18F]-setoperone PET technique for assessing the binding potential (Bmax/ Kd) for 5-HT2 receptors. Ten healthy subjects had two [18F]-setoperone PET scans on two separate occasions 6-21 days apart. The average difference in the 5-HT2 binding potential (BP) as measured on the two occasions in the prefrontal, temporal, parietal and occipital region was between 5 and 7%. Thus 5-HT2 BP can be measured with a high reliability using a non-invasive technique that uses the cerebellum as a reference region. A power analysis based on the reliability data suggests that this technique can be used to detect within-subject differences of 10% or more, and between-group differences of 25% or more, with a reasonable number of subjects. It is concluded that [18F]-setoperone can be routinely produced and reliably used for the PET imaging of 5-HT2 receptors in clinical situations.


Neuropsychopharmacology | 2000

Instrumentally Detected Changes in Motor Functioning in Patients with Low Levels of Antipsychotic Dopamine D2 Blockade

Paul B. Fitzgerald; Shitij Kapur; Michael P. Caligiuri; Corey Jones; Simone Silvestri; Gary Remington; Robert B. Zipursky

Extrapyramidal side-effects (EPSE) of antipsychotic medication are related to the occupancy of dopamine D2 receptors and there appears to be a threshold of D2 occupancy below which clinically EPSE are unlikely to occur. It is unclear whether there are motor changes produced by ‘subthreshold’ levels of D2 occupancy that are not detectable by clinical examination. This study was designed to investigate whether a number of electromechanical instrumental techniques could detect ‘subthreshold’ motor changes and whether these changes correlate with dopamine D2 occupancy as measured by [11C]-raclopride PET scan. Twenty medication naïve patients were studied before and during treatment with low dose haloperidol. Instrumental techniques detected an asymmetrical worsening in motor function with drug treatment despite the failure of the group to experience significant EPSE. These changes did not correlate with D2 occupancy and measurements of rigidity, tremor, and bradykinesia did not closely inter-correlate.


American Journal of Psychiatry | 2000

Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

Shitij Kapur; Robert B. Zipursky; Corey Jones; Gary Remington; Sylvain Houle


Archives of General Psychiatry | 2000

A Positron Emission Tomography Study of Quetiapine in Schizophrenia: A Preliminary Finding of an Antipsychotic Effect With Only Transiently High Dopamine D2 Receptor Occupancy

Shitij Kapur; Robert B. Zipursky; Corey Jones; C. S. Shammi; Gary Remington; Philip Seeman


American Journal of Psychiatry | 1998

5-HT2 and D2 Receptor Occupancy of Olanzapine in Schizophrenia: A PET Investigation

Shitij Kapur; Robert B. Zipursky; Gary Remington; Corey Jones; Jean N. DaSilva; Alan A. Wilson; Sylvain Houle


American Journal of Psychiatry | 1996

High Levels of Dopamine D2 Receptor Occupancy With Low-Dose Haloperidol Treatment: A PET Study

Shitij Kapur; Gary Remington; Corey Jones; Alan A. Wilson; Jean N. DaSilva; Sylvain Houle; Robert B. Zipursky


American Journal of Psychiatry | 1999

Serotonin 5-HT2 Receptors in Schizophrenia: A PET Study Using [18F]Setoperone in Neuroleptic-Naive Patients and Normal Subjects

Ralph Lewis; Shitij Kapur; Corey Jones; Jean N. DaSilva; Gregory M. Brown; Alan A. Wilson; Sylvain Houle; Robert B. Zipursky


The Journal of Clinical Psychiatry | 2002

Quetiapine: An Effective Antipsychotic in First-Episode Schizophrenia Despite Only Transiently High Dopamine-2 Receptor Blockade

Sitra Tauscher-Wisniewski; Shitij Kapur; Johannes Tauscher; Corey Jones; Zafiris J. Daskalakis; George Papatheodorou; Irvin Epstein; Bruce K. Christensen; Robert B. Zipursky

Collaboration


Dive into the Corey Jones's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gary Remington

Centre for Addiction and Mental Health

View shared research outputs
Top Co-Authors

Avatar

Sylvain Houle

Centre for Addiction and Mental Health

View shared research outputs
Top Co-Authors

Avatar

Alan A. Wilson

Centre for Addiction and Mental Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Raymond Y. Cho

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G. McKay

University of Saskatchewan

View shared research outputs
Top Co-Authors

Avatar

Gregory M. Brown

Centre for Addiction and Mental Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge